参考文献/References:
[1]Rusinaru D,Leborgne L,Peltier M,et al. Effect of atrial fibrillation on long-term survival in patients hospitalised for heart failure with preserved ejection fraction[J]. Eur J Heart Fail,2008,10(6):566-572.
[2]Liu G ,Long M ,Hu X ,et al. Meta-analysis of atrial fibrillation and outcomes in patients with heart failure and preserved ejection fraction[J]. Heart Lung Circ,2021,30(5):698-706.
[3]Zakeri R ,Borlaug BA ,McNulty SE ,et al. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction:a RELAX trial ancillary study[J]. Circ Heart Fail,2014,7(1):123-130.
[4]Gorter TM ,van Melle JP ,Rienstra M ,et al. Right heart dysfunction in heart failure with preserved ejection fraction:the impact of atrial fibrillation[J]. J Card Fail,2018,24(3):177-185.
[5]Elshazly MB ,Senn T ,Wu Y ,et al. Impact of atrial fibrillation on exercise capacity and mortality in heart failure with preserved ejection fraction:insights from cardiopulmonary stress testing[J]. J Am Heart Assoc,2017,6(11):e006662.
[6]Son MK ,Park JJ ,Lim NK ,et al. Impact of atrial fibrillation in patients with heart failure and reduced,mid-range or preserved ejection fraction[J]. Heart,2020,106(15):1160-1168.
[7]O’Neal WT ,Sandesara P ,Hammadah M ,et al. Gender differences in the risk of adverse outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction[J]. Am J Cardiol,2017,119(11):1785-1790.
[8]Yagawa M ,Nagatomo Y ,Izumi Y ,et al. Effect of obesity on the prognostic impact of atrial fibrillation in heart failure with preserved ejection fraction[J]. Circ J,2017,81(7):966-973.
[9]张冰玉,刘宇翔,刘培良,et al. 射血分数保留的心力衰竭中右心室功能不全的研究进展[J]. 中国医刊,2021,56(4):378-381.
[10]Obokata M ,Reddy YNV ,Melenovsky V ,et al. Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction[J]. Eur Heart J,2019,40(8):689-697.
[11]Ikoma T ,Obokata M ,Okada K ,et al. Impact of right atrial remodeling in heart failure with preserved ejection fraction[J]. J Card Fail,2021,27(5):577-584.
[12]Harada T ,Obokata M ,Omote K ,et al. Functional tricuspid regurgitation and right atrial remodeling in heart failure with preserved ejection fraction[J]. Am J Cardiol,2022,162:129-135.
[13]吕致,董杨,陈玉成. 心脏磁共振在肺动脉高压右心室评价中的应用[J]. 心血管病学进展,2019,40(1):16-19.
[14]Ozcan C ,Allan T ,Besser SA ,et al. The relationship between coronary microvascular dysfunction,atrial fibrillation and heart failure with preserved ejection fraction[J]. Am J Cardiovasc Dis,2021,11(1):29-38.
[15]Zhou H ,Tang W ,Yang J ,et al. MicroRNA-related strategies to improve cardiac function in heart failure[J]. Front Cardiovasc Med,2021,8:773083.
[16]Zhao H ,Yang H ,Geng C ,et al. Elevated IgE promotes cardiac fibrosis by suppressing miR-486a-5p[J]. Theranostics,2021,11(15):7600-7615.
[17]Charrier H ,Cuvelliez M ,Dubois-Deruy E ,et al. Integrative system biology analyses identify seven microRNAs to predict heart failure[J]. Noncoding RNA,2019,5(1):22.
[18]Zhang GQ ,Wang SQ ,Chen Y ,et al. MicroRNAs regulating mitochondrial function in cardiac diseases[J]. Front Pharmacol,2021,12:663322.
[19]Mesquita TRR ,Zhang R ,Couto G de ,et al. Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction[J]. Heart Rhythm,2020,17(6):1025-1033.
[20]Nolte K ,Herrmann-Lingen C ,Platschek L ,et al. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction[J]. ESC Heart Fail,2019,6(2):262-279.
[21]叶学群,罗骥,曹彦,等. 经食道超声心动图评估持续性房颤患者心脏结构和心室功能的价值[J]. 安徽医学,2021,42(7):778-781.
[22]Arita VA ,Santema BT ,Ruben R ,et al. Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction:Data from the AF-RISK study[J]. Am Heart J,2022,244:36-41.
[23]Sch?nbauer R ,Duca F ,Kammerlander AA ,et al. Persistent atrial fibrillation in heart failure with preserved ejection fraction:prognostic relevance and association with clinical,imaging and invasive haemodynamic parameters[J]. Eur J Clin Invest,2020,50(2):e13184.
[24]Gorter TM ,van Veldhuisen DJ ,Bauersachs J ,et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction:mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology[J]. Eur J Heart Fail,2018,20(1):16-37.
[25]Rieth AJ ,Richter MJ ,Tello K ,et al. Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction:key role of the right heart[J]. Clin Res Cardiol,2022,111(4):393-405.
[26]Kanagala P ,Arnold JR ,Singh A ,et al. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction[J]. Int J Cardiovasc Imaging,2021,37(1):255-266.
[27]Guazzi M ,Dixon D ,Labate V ,et al. RV contractile function and its coupling to pulmonary circulation in heart failure with preserved?ejection?fraction:stratification of clinical phenotypes and outcomes[J]. JACC Cardiovasc Imaging,2017,10(10 Pt B):1211-1221.
[28]Berglund F ,Pi?a P ,Herrera CJ . Right ventricle in heart failure with preserved ejection fraction[J]. Heart,2020,106(23):1798-1804.
[29]Nakagawa A ,Yasumura Y ,Yoshida C ,et al. Prognostic importance of right ventricular-vascular uncoupling in acute decompensated heart failure with preserved ejection fraction[J]. Circ Cardiovasc Imaging,2020,13(11):e011430.
[30]Gorter TM ,van Veldhuisen DJ ,Voors AA ,et al. Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension[J]. Eur Heart J Cardiovasc Imaging,2018,19(4):425-432.
[31]Sugimoto T ,Bandera F ,Generati G ,et al. Left atrial function dynamics during?exercise in heart failure:pathophysiological implications on the right heart and exercise ventilation inefficiency[J]. JACC Cardiovasc Imaging,2017,10(10 Pt B):1253-1264.
[32]Zhang J ,Xu M ,Chen T ,et al. Correlation between liver stiffness and diastolic function,left ventricular hypertrophy,and right cardiac function in patients with ejection fraction preserved heart failure[J]. Front Cardiovasc Med,2021,8:748173.
[33]汤飞云,冯泽阳,叶香华. 实时三维超声心动图定量评估肝硬化患者右心房容积功能特征[J]. 心脑血管病防治,2018,18(6):461-464.
[34]Reddy YNV ,Obokata M ,Verbrugge FH ,et al. Atrial dysfunction in patients with?heart?failure with preserved ejection fraction?and?atrial?fibrillation[J]. J Am Coll Cardiol,2020,76(9):1051-1064.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(8):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(8):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(8):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(8):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(8):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]